Boehringer Ingelheim: Thromboembolism trials

The registry lists 12 Thromboembolism studies with Boehringer Ingelheim as lead sponsor. 0 are open to participants now and 12 have results posted.

Phase 2 1Phase 3 7No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PraxbindTM India PMS ProgramCompletedNCT03359889Results posted
• A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)CompletedNCT02913326Phase 3Results posted
• Follow on Study From RE-ALIGNTerminatedNCT01505881Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement SurgeryTerminatedNCT00967447Results posted
• Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement SurgeryCompletedNCT00847301Results posted
• Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement SurgeryCompletedNCT00846807Results posted
• Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)CompletedNCT00680186Phase 3Results posted
• Secondary Prevention of Venous Thrombo Embolism (VTE).CompletedNCT00329238Phase 3Results posted
• Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous ThromboembolismCompletedNCT00291330Phase 3Results posted
• Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement SurgeryCompletedNCT00168818Phase 3Results posted
• RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee SurgeryCompletedNCT00168805Phase 3Results posted
• Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee ReplacementCompletedNCT00152971Phase 3Results posted